國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Progress in cancer immunotherapy

SpringerLink (Online service)

Progress in cancer immunotherapy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Progress in cancer immunotherapyedited by Shuren Zhang.
其他作者:	Zhang, Shuren.
出版者:	Dordrecht :Springer Netherlands :2016.
面頁冊數:	xii, 283 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	CancerImmunotherapy.
電子資源:	http://dx.doi.org/10.1007/978-94-017-7555-7
ISBN:	9789401775557$q(electronic bk.)

Progress in cancer immunotherapy
Progress in cancer immunotherapy[electronic resource] /edited by Shuren Zhang. - Dordrecht :Springer Netherlands :2016. - xii, 283 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.9090065-2598 ;. - Advances in experimental medicine and biology ;946..

Antibody therapies in cancer -- Biological Response Modifier in Cancer Immunotherapy -- Progress and Development of Therapeutic Cancer Vaccines -- Adoptive Cellular Therapy (ACT) for Cancer Treatment -- Oncolytic Immunotherapy for Treatment of Cancer.

This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.

ISBN: 9789401775557$q(electronic bk.)

Standard No.: 10.1007/978-94-017-7555-7doiSubjects--Topical Terms:

201873
Cancer
--Immunotherapy.

LC Class. No.: RC271.I45

Dewey Class. No.: 616.99406

Progress in cancer immunotherapy
LDR:02101nmm a2200325 a 4500 001 489010
003 DE-He213
005 20161019150640.0
006 m d
007 cr nn 008maaau
008 161213s2016 ne s 0 eng d
020 $a 9789401775557$q(electronic bk.)
020 $a 9789401775533$q(paper)
024 7 $a 10.1007/978-94-017-7555-7 $2 doi
035 $a 978-94-017-7555-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I45
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
082 0 4 $a 616.99406 $2 23
090 $a RC271.I45 $b P964 2016
245 0 0 $a Progress in cancer immunotherapy $h [electronic resource] / $c edited by Shuren Zhang.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2016.
300 $a xii, 283 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.909
505 0 $a Antibody therapies in cancer -- Biological Response Modifier in Cancer Immunotherapy -- Progress and Development of Therapeutic Cancer Vaccines -- Adoptive Cellular Therapy (ACT) for Cancer Treatment -- Oncolytic Immunotherapy for Treatment of Cancer.
520 $a This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.
650 0 $a Cancer $x Immunotherapy. $3 201873
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Human Genetics. $3 273658
650 2 4 $a Antibodies. $3 456407
650 2 4 $a Vaccine. $3 337782
650 2 4 $a Oncology. $3 195181
700 1 $a Zhang, Shuren. $3 747219
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u http://dx.doi.org/10.1007/978-94-017-7555-7
950 $a Biomedical and Life Sciences (Springer-11642)